CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.

Pharmaceutical

CStone Pharmaceuticals

Jason Yang

Jason Li

Lian Liu

Qingmei Shi

Na Wen

Chao Arthur Wu

Juan Zhang

Anny-Yue Yin

Michael Choi

Josh Zhou

Clinical and Medical Science Team

Leadership Team

Marketing and Communications

Teams at CStone Pharmaceuticals

Clinical and Medical Science Team

Leadership Team

Marketing and Communications